Imagine stepping into your local Costco and walking out with a popular weight loss drug that’s not only effective but also potentially cheaper than before. Starting this Friday, that dream becomes a reality as Novo Nordisk teams up with Costco to make Ozempic and Wegovy available at their pharmacies, providing an easy pathway for those struggling with weight management.

Ozempic and Wegovy, both GLP-1 prescription injectables, have gained massive popularity not just for treating Type 2 diabetes but also as powerful allies in the weight loss journey. While these medications have been a game changer for many, their price tag often becomes a barrier. But for Costco members, the out-of-pocket cost is set at $499, making them more accessible than ever—provided you’re part of the Costco Member Prescription Program.

This initiative marks a significant step in Novo Nordisk's aim to broaden the reach of its injectables across the U.S., breaking down financial barriers to essential health care. Dave Moore, Executive Vice President of U.S. Operations at Novo Nordisk, highlighted the company’s commitment, stating, “Everyone deserves care that’s simple, reliable, and within reach — and we’re proud to lead the way in helping make that a reality.”

It’s worth noting that other retail pharmacies have also partnered with Novo Nordisk, but this collaboration with Costco puts these medications directly into the hands of millions of health-conscious consumers who frequent the warehouse store.